Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan

Takuya Watanabe; Yuichi Temma; Junichi Okada; Eijiro Yamada; Tsugumichi Saito; Kazuya Okada; Yasuyo Nakajima; Atsushi Ozawa; Tetsuya Takamizawa; Mitsuaki Horigome; Shuichi Okada; Masanobu Yamada

Return

Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan

VernacularTitle:Influence of the stage of emergency declaration due to the coronavirus disease 2019 outbreak on plasma glucose control of patients with diabetes mellitus in the Saku region of Japan
Author: Takuya WATANABE ¹ ; Yuichi TEMMA ¹ ; Junichi OKADA ² ; Eijiro YAMADA ³ ; Tsugumichi SAITO ³ ; Kazuya OKADA ⁴ ; Yasuyo NAKAJIMA ³ ; Atsushi OZAWA ³ ; Tetsuya TAKAMIZAWA ¹ ; Mitsuaki HORIGOME ¹ ; Shuichi OKADA ³ ; Masanobu YAMADA ³
Author Information

1. Department of Endocrinology and Metabolism, Saku Central Hospital Advanced Care Center, Japan
2. Department of Medicine, Division of Endocrinology, Albert Einstein College of Medicine, USA
3. Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Japan
4. Omagari Kosei Medical Center, Japan
Keywords: Coronavirus disease 2019; COVID-19; Diabetes mellitus; HbA1c
From:Journal of Rural Medicine 2021;16(2):98-101
CountryJapan
Language:English
Abstract: Objective: Because patients with diabetes mellitus (DM) were forced to stay indoors during the state of emergency, resulting in stress and a lack of physical activity, concerns about their glycemic control were raised.Patients and Methods: The 165 patients’ glycated hemoglobin (HbA1c) levels were compared during the following periods: the 4 months that were selected as a representative condition 1 year before the COVID-19 pandemic (May 2018, March 2019, June 2019, and July 2019) and the latter 3 months as a 1-year follow-up during the COVID-19 pandemic (May 2019, March 2020, June 2020, and July 2020).Results: The patients’ HbA1c levels were 7.32 ± 1.23, 7.44 ± 1.20, 7.16 ± 1.06, 7.01 ± 1.05, 7.23 ± 1.06, 7.45 ± 1.18, 7.15 ± 10.7, and 7.11 ± 1.17 in May 2018, March 2019, June 2019, July 2019, May 2019, March 2020, June 2020, and July 2020, respectively (expressed as mean ± standard deviation).Conclusion: The analysis showed that HbA1c levels did not worsen during the self-restraint period.